Advertisement

Topics

Rodman & Renshaw Conferences, LLC Company Profile

09:44 EDT 26th August 2016 | BioPortfolio


News Articles [218 Associated News Articles listed on BioPortfolio]

Valeant Pharmaceuticals-Aktie: Restatements sind niemals gut, aber... - Aktienanalyse

New York - Valeant Pharmaceuticals-Aktienanalyse von Analyst Raghuram Selvaraju von Rodman & Renshaw: Raghuram Selvaraju, Aktienanalyst vom Investmenthaus Rodman & Renshaw, spricht im Rahmen einer ...

Valeant Pharmaceuticals-Aktie: Ausblick fällt positiv ins Gewicht! - Aktienanalyse

New York - Valeant Pharmaceuticals-Aktienanalyse von Analyst Raghuram Selvaraju von Rodman & Renshaw: Raghuram Selvaraju, Aktienanalyst vom Investmenthaus Rodman & Renshaw, spricht im Rahmen einer ...

Rodman starts BioSpecifics at buy

Rodman & Renshaw has started coverage of BioSpecifics Technologies (NASDAQ:BSTC) with a “buy” rating and 12-month price target of $60. The stock closed at $35.97 on Monday. The company’s sol...

Rodman starts Nanosphere at buy

Rodman & Renshaw has launched coverage of Nanosphere (NASDAQ:NSPH) with a “buy” rating and price target of $2. The stock closed at 87 cents on Monday. “In our view, the company’s Verigene ...

Rodman starts OpGen at buy

Rodman & Renshaw has initiated coverage of OpGen (NASDAQ:OPGN) with a “buy” rating and 12-month price target of $2.50. The stock closed at $1.56 on Tuesday. “In our view, the company’s Qui...

Rodman starts Presbia at buy

Rodman & Renshaw has initiated coverage of Presbia PLC (NASDAQ:LENS) with the “buy” rating and 18-month price target of $14. The stock closed at $3.90 on Tuesday. Presbia has a novel corneal i...

Rodman starts Bio-Path at buy

Rodman & Renshaw has launched coverage of Bio-Path Holdings (NASDAQ:BPTH) with a “buy” rating and a 12-month price target of $5. The stock closed at $2.76 on Monday. “In our view, Bio-Path...

Rodman starts NeuroMetrix at buy

Rodman & Renshaw has initiated coverage of NeuroMetrix (NASDAQ:NURO) with a “buy” rating and 12-month price target of $4.50. The stock closed at $1.74 on Tuesday. NeuroMetrix is a commercial-s...

Drugs and Medications [5 Associated Drugs and Medications listed on BioPortfolio]

Creon [Abbott Products, Inc.]

These highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON.CREON (pancrelipase) delayed-release capsules for oral useIni...

Pancreaze [Ortho-McNeil-Janssen Pharmaceutical, Inc.]

These highlights do not include all the information needed to use PANCREAZE™ safely and effectively. See full prescribing information for PANCREAZE™.  PANCREAZE™ (pancrelipase) delayed-release ...

Creon [Physicians Total Care, Inc.]

These highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON. CREON (pancrelipase) capsule, delayed release for oral use I...

Pancrelipase [X-GEN Pharmaceuticals, Inc.]

These highlights do not include all the information needed to use pancrelipase safely and effectively. See full prescribing information for pancrelipase. pancrelipase (pancrelipase) CAPSULE, DELAYED R...

Zenpep [Eurand Pharmaceuticals Inc.]

These highlights do not include all the information needed to use ZENPEP safely and effectively. See full prescribing information for ZENPEP. ZENPEP (pancrelipase) delayed release capsules Initial U.S...

PubMed Articles [57 Associated PubMed Articles listed on BioPortfolio]

A Procedural Approach to Teaching Residents To Conduct Intensive Care Unit Family Conferences.

Family conferences are an essential component of high-quality ICU care and an important skill for physicians. For residents, intensive care unit (ICU) rotations represent an opportunity to learn to co...

Learning by (video) example: a randomized study of communication skills training for end-of-life and error disclosure family care conferences.

Teaching residents to lead end of life (EOL) and error disclosure (ED) conferences is important.

Family Conferences in the Neonatal ICU: Observation of Communication Dynamics and Contributions.

Clinicians in the neonatal ICU must engage in clear and compassionate communication with families. Empirical, observational studies of neonatal ICU family conferences are needed to develop counseling ...

Quantitative Study of the Characteristics of Effective Internal Medicine Noon Conference Presentations.

Background Increasing demands on residents' time have made it critically important to maximize the effectiveness of didactic activities and motivate independent study. Objective Our aim was to cor...

A Theoretical Model for the Associative Nature of Conference Participation.

Participation in conferences is an important part of every scientific career. Conferences provide an opportunity for a fast dissemination of latest results, discussion and exchange of ideas, and broad...

Clinical Trials [12 Associated Clinical Trials listed on BioPortfolio]

Intervention of Psychological and Ethical Professionals of Human Science in Obstetrical Morbidity and Mortality Conferences (OPEN : Organization, Practices Evaluation in Perinatal Network)

This cluster-randomised controlled trial will test the hypothesis that a multifaceted program with psychological intervention in morbidity mortality conferences (MMC) improve care quality ...

The Effect of Case Conferencing in Nursing Homes

This study evaluates the effect of using comprehensive geriatric assessment in combination with case conferences on the prevalence of neuropsychiatric symptoms (also known as behavioral an...

How Does the Spirituality of Patients With Type 2 Diabetes Influence Their Self-management?

This exploratory study is researching how the spirituality of a group of British patients with type 2 diabetes (T2D), impacts their approach to the self-management of their condition. ...

Distant Delivery of a Mindfulness-based Intervention for People Affected by Parkinson's Disease

Psychological difficulties, especially depression and anxiety are the most prevalent non-motor symptoms in Parkinson's Disease (PD). Pharmacological treatments are not as effective in PD. ...

Impact of a Psychoeducational Intervention on Expectations and Coping in Young Women Exposed to a High HBOC Risk

Young female counselees (18-30 years) belonging to HBOC families with a known mutation on BRCA-genes or not, receive a lot of information regarding their cancer risk. Information sources a...

Companies [180 Associated Companies listed on BioPortfolio]

Rodman & Renshaw, LLC

Rodman & Renshaw Capital Group, Inc. (NASDAQ: RODM) is a holding company with a number of direct and indirect subsidiaries, including Rodman & Renshaw, LLC.

Rodman & Renshaw Conferences, LLC

Rodman & Renshaw, LLC Rodman & Renshaw, LLC and Cowen and Company acts as Exclusive Co-Placement Agents to Access Pharmaceuticals, Inc. in the Private Placement of $5.2 Million

Advaxis, Inc. and Rodman & Renshaw, LLC

Advaxis is a biotechnology company developing the next generation of immunotherapies for cancer and infectious diseases. Advaxis immunotherapies are based on a novel platform tech...

Rodman Publishing

Rodman Publishing, based in Ramsey, New Jersey, has been a leading publisher of trade publications for more than four decades. Established in 1964, Rodman Publishing has been the leading source of inf...

More Information about "Rodman & Renshaw Conferences, LLC" on BioPortfolio

We have published hundreds of Rodman & Renshaw Conferences, LLC news stories on BioPortfolio along with dozens of Rodman & Renshaw Conferences, LLC Clinical Trials and PubMed Articles about Rodman & Renshaw Conferences, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Rodman & Renshaw Conferences, LLC Companies in our database. You can also find out about relevant Rodman & Renshaw Conferences, LLC Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record